StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Brooklyn ImmunoTherapeutics stock opened at $2.06 on Wednesday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 […]